Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China
· Delayed Price · Currency is CNY 162.32
+25.92 (19.00%)
Jun 9, 2025, 2:45 PM CST
Beijing Hotgen Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | - | - | 27.38 | 944.74 | 2,186 | 112.07 | Upgrade
|
| Depreciation & Amortization | - | - | 69.4 | 120.29 | 68.34 | 29.15 | Upgrade
|
| Other Amortization | - | - | 8.89 | 28.15 | 5.38 | 10.94 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.64 | 0.34 | 14.21 | 0.18 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 36.95 | 70.06 | 8.51 | 0.14 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 22.31 | -10.91 | -24.88 | -8.13 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -13.15 | 11.34 | 0.7 | 1.2 | Upgrade
|
| Other Operating Activities | - | - | -59.79 | 94.17 | 118.58 | -2.02 | Upgrade
|
| Change in Accounts Receivable | - | - | 92.84 | -22.28 | -81.52 | -19.87 | Upgrade
|
| Change in Inventory | - | - | 123.52 | 36.03 | -213.43 | -60.14 | Upgrade
|
| Change in Accounts Payable | - | - | -285.1 | -242.99 | 564.77 | 97.55 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -71.27 | -32.27 | 8.46 | 4.3 | Upgrade
|
| Operating Cash Flow | - | - | -51.95 | 978.75 | 2,644 | 164.62 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -62.99% | 1506.38% | 749.79% | Upgrade
|
| Capital Expenditures | - | - | -413.36 | -565.21 | -398.86 | -172.27 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 3.74 | 0.58 | 0.13 | 0.05 | Upgrade
|
| Divestitures | - | - | -17.42 | -0.08 | - | - | Upgrade
|
| Investment in Securities | - | - | 238.61 | -602.42 | -1,367 | - | Upgrade
|
| Other Investing Activities | - | - | 26.56 | 17.08 | 22.34 | 8.13 | Upgrade
|
| Investing Cash Flow | - | - | -161.87 | -1,130 | -1,763 | -164.1 | Upgrade
|
| Long-Term Debt Repaid | - | - | -27.24 | -32.29 | -11.4 | -23.75 | Upgrade
|
| Total Debt Repaid | - | - | -27.24 | -32.29 | -11.4 | -23.75 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -27.24 | -32.29 | -11.4 | -23.75 | Upgrade
|
| Issuance of Common Stock | - | - | 3.34 | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -16.44 | -150.04 | - | - | Upgrade
|
| Common Dividends Paid | - | - | - | -310.98 | -93.29 | -19.1 | Upgrade
|
| Other Financing Activities | - | - | 3.8 | 8.32 | 9.63 | 0.69 | Upgrade
|
| Financing Cash Flow | - | - | -36.55 | -484.99 | -95.07 | -42.16 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | -0.46 | 5.2 | -14.83 | 1.4 | Upgrade
|
| Net Cash Flow | - | - | -250.83 | -631.09 | 771.69 | -40.23 | Upgrade
|
| Free Cash Flow | - | - | -465.31 | 413.54 | 2,246 | -7.65 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -81.58% | - | - | Upgrade
|
| Free Cash Flow Margin | - | - | -85.97% | 11.63% | 41.82% | -1.49% | Upgrade
|
| Free Cash Flow Per Share | - | - | -5.27 | 4.50 | 24.40 | -0.08 | Upgrade
|
| Cash Income Tax Paid | - | - | 19.79 | 371.82 | 312.86 | 0.66 | Upgrade
|
| Levered Free Cash Flow | - | - | -561.32 | 129.6 | 1,644 | -35.57 | Upgrade
|
| Unlevered Free Cash Flow | - | - | -560.69 | 131.05 | 1,645 | -35.29 | Upgrade
|
| Change in Net Working Capital | 396.3 | - | 196.3 | 143.77 | -353.02 | -22.32 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.